Galmed Pharmaceuticals (GLMD) Change in Accured Expenses (2015)

Galmed Pharmaceuticals (GLMD) recorded quarterly Change in Accured Expenses of $224000.0 in Q2 2015, up 214.87% quarter-over-quarter from -$195000.0 in Q1 2015.

Galmed Pharmaceuticals (GLMD) Change in Accured Expenses (2015) Analysis & Trends

Galmed Pharmaceuticals' Change in Accured Expenses history runs 1 years deep, the most recent figure standing at $224000.0 for Q2 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Galmed Pharmaceuticals 2.48 Mn -1.63 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2015 224,000.00
Jun 30, 2015 224,000.00
Mar 31, 2015 -195,000.00
Mar 31, 2015 -195,000.00